Tissue engineering of diseased bladder using a collagen scaffold in a bladder exstrophy model

BJU International

Volumn 114, Issue 3, 2014, Pages 447-457

  Roelofs, Luc A J ^a   Kortmann, Barbara B M ^a   Oosterwijk, Egbert ^a   Eggink, Alex J ^b   Tiemessen, Dorien M ^a   Crevels, A Jane ^a   Wijnen, Rene M H ^b   Daamen, Willeke F ^a   Van Kuppevelt, Toin H ^a   Geutjes, Paul J ^a   Feitz, Wout F J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

bladder exstrophy; collagen scaffold; diseased bladder; sheep; tissue engineering

Indexed keywords

COLLAGEN; COLLAGEN SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER EXSTROPHY; CELL MATURATION; CONTROLLED STUDY; CYSTOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; FETUS; GESTATIONAL AGE; HISTOPATHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SHEEP; SMOOTH MUSCLE FIBER; SUBMUCOSA; SURVIVAL RATE; TISSUE ENGINEERING; TISSUE REGENERATION; URODYNAMICS; VIDEO URODYNAMICS;

ANIMALS; ANIMALS, NEWBORN; BLADDER EXSTROPHY; CATTLE; COLLAGEN; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; MYOCYTES, SMOOTH MUSCLE; REGENERATION; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLDS; URINARY BLADDER; URODYNAMICS;

EID: 84906690480     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12591     Document Type: Article

References (35)

1. Adams MC, Joseph DB,. Urinary tract reconstruction in children. In, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds, Campbell-Walsh Urology, 10th edn, Vol. 1, Section 17, Chapter 129. Philadelphia, PA: Saunders, 2012: 3457-3502
2. Hendren WH, Hendren RB,. Bladder augmentation: experience with 129 children and young adults. J Urol 1990; 144: 445-453 (Pubitemid 20236832)
3. Mills RD, Studer UE,. Metabolic consequences of continent urinary diversion. J Urol 1999; 161: 1057-1066 (Pubitemid 29426087)
4. Austen M, Kalble T,. Secondary malignancies in different forms of urinary diversion using isolated gut. J Urol 2004; 172: 831-838 (Pubitemid 39096403)
5. Sievert K, Amend B, Stenzl A,. Tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 2007; 52: 1580-1589 (Pubitemid 350052422)
6. Yoo JJ, Olson J, Atala A, Kim B,. Regenerative medicine strategies for treating neurogenic bladder. Int Neurourol J 2011; 15: 109-119
7. Clayton DB, Brock JW III, Joseph DB,. Urologic management of spina bifida. Dev Disabil Res Rev 2010; 16: 88-95
8. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB,. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-1246
9. Joseph D, Borer J, De Filippo R, et al. A phase 2 study-tengion autologous neo-bladder augment™ (NBA) for augmentation cystoplasty in subjects with neurogenic bladder secondary to spina bifida. J Urol 2009; 181: 555-556 (LBA2)
10. Oerlemans AJ, Feitz WF, van Leeuwen E, Dekkers WJ,. Regenerative urology clinical trials: an ethical assessment of road blocks and solutions. Tissue Engin Part B 2013; 19: 41-47
11. Fry CH, Bayliss M, Young JS, Hussain M,. Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle. BJU Int 2010; 108: 91-96
12. Subramaniam R, Hinley J, Stahlschmidt J, Southgate J,. Tissue engineering potential of urothelial cells from diseased bladders. J Urol 2011; 186: 2014-2020
13. Rubenwolf PC, Eder F, Ebert A, Hofstaedter F, Roesch WH,. Expression and potential clinical significance of urothelial cytodifferentiation markers in the exstrophic bladder. J Urol 2012; 187: 1806-1811
14. Lai J, Yoon CY, Yoo JJ, Wulf T, Atala A,. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol 2002; 168: 1853-1858 (Pubitemid 35034105)
15. Lin H, Cowan R, Moore P, et al. Characterization of neuropathic bladder smooth muscle cells in culture. J Urol 2004; 171: 1348-1352 (Pubitemid 38327608)
16. Orsola A, Estrada CR, Nguyen HT, et al. Growth and stretch response of human exstrophy bladder smooth muscle cells: molecular evidence of normal intrinsic function. BJU Int 2005; 95: 144-148 (Pubitemid 350020887)
17. Dozmorov MG, Kropp BK, Hurst RE, Cheng EY, Lin H,. Differentially expressed gene networks in cultured smooth muscle cells from normal and neuropathic bladder. J Smooth Muscle Res 2007; 43: 55-72
18. Suson KD, Stec AA, Shimoda LA, Gearhart JP,. Initial characterization of extrophy bladder smooth muscle cells in culture. J Urol 2012; 188: 1521-1527
19. Hipp J, Andersson K, Kwon TG, Kwak EK, Yoo J, Atala A,. Microarray analysis of exstrophic human bladder smooth muscle. BJU Int 2007; 101: 100-105
20. Hipp JA, Hipp JD, Yoo JJ, Atala A, Andersson K,. Microaaray analysis of bladder smooth muscle from patients with myelomeningocele. BJU Int 2008; 102: 741-746
21. Zhang Y, Frimberger D, Cheng EY, Lin H, Kropp BP,. Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 2006; 98: 1100-1105 (Pubitemid 44536466)
22. Akbal C, Lee SD, Packer SC, Davis MM, Rink RC, Kaefer M,. Bladder augmentation with acellular dermal biomatrix in a diseased animal model. J Urol 2006; 176: 1706-1711 (Pubitemid 44291740)
23. Slaughenhoupt BL, Chen CJ, Gearhart JP,. Creation of a model of bladder exstrophy in the fetal lamb. J Urol 1996; 156: 816-818 (Pubitemid 126444933)
24. Fauza DO, Fishman SJ, Mehegan K, Atala A,. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg 1998; 33: 7-12 (Pubitemid 28060370)
25. Roelofs LA, Eggink AJ, Hulsbergen-van de Kaa CA, et al. Fetal bladder wall regeneration with a collagen biomatrix and histological evaluation of bladder exstrophy in a fetal sheep model. Fetal Diagn Ther 2008; 24: 7-14 (Pubitemid 352009137)
26. Pieper JS, Oosterhof A, Dijkstra PJ, Veerkamp JH, van Kuppevelt TH,. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 1999; 20: 847-858 (Pubitemid 29184766)
27. Daamen WF, Van Moerkerk HT, Hafmans T, et al. Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials 2003; 24: 4001-4009 (Pubitemid 36794404)
28. Pieper JS, Hafmans T, Veerkamp JH, van Kuppevelt TH,. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 2000; 21: 581-593 (Pubitemid 30083922)
29. Hosper NA, Eggink AJ, Roelofs LA, et al. Intra-uterine tissue engineering of full-thickness skin defects in a fetal sheep model. Biomaterials 2010; 31: 3910-3919
30. Gilbert DL, Kim SW,. Macromolecular release from collagen monolithic devices. J Biomed Mater Res 1990; 24: 1221-1239 (Pubitemid 20269713)
31. Olde Damink LH, Dijkstra PJ, van Luyn MJ, van Wachem PB, Nieuwenhuis P, Feijen J,. Cross-linking of dermal sheep collagen using a water-soluble carbo-diimide. Biomaterials 1996; 17: 765-773 (Pubitemid 26108344)
32. Wei W, Howard PS, Kogan B, Macarak EJ,. Urinary diversion results in marked decreases in proliferation and apoptosis in fetal bladder. J Urol 2012; 188: 1306-1312
33. Nuininga JE, Koens MJ, Tiemessen DM, et al. Urethral reconstruction of critical defects in rabbits using molecularly defined tubular type I collagen biomatrices: key issues in growth factor addition. Tissue Engin Part A 2010; 16: 3319-3328
34. Sun W, Tiemessen DM, Sloff M, et al. Improving the cell distribution in collagen-coated poly-caprolactone knittings. Tissue Engin Part C 2012; 18: 731-739
35. Hartmann-Fritsch F, Hosper N, Luginbühl J, Biedermann T, Reichmann E, Meuli M,. Human amniotic fluid derived cells can competently substitute dermal fibroblasts in a tissue-engineered dermo-epidermal skin analog. Pediatr Surg Int 2013; 29: 61-69